ICL (ICL) Reports In-Line Q4 EPS

ICL (NYSE: ICL) reported Q4 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.13 billion.

ICL's President & CEO, Raviv Zoller, stated, "ICL achieved several important milestones in 2019, the most recent of which was the upgrade of our Dead Sea facilities. While ICL's results for the fourth quarter were impacted by disruptions associated with the upgrade, a weak environment for commodity fertilizers and the unfavorable impact of exchange rates, we believe that the actions we have taken throughout 2019 have significantly strengthened ICL's position and prospects to create value for our shareholders for years to come."

Zoller continued, "In addition to upgrading our capacity in the Dead Sea, we also completed the construction of our new food grade phosphoric acid plant in China that will allow us to shift from commodity phosphates to specialty products. We also introduced breakthrough solutions for plant-based meat alternatives and executed strategic long-term agreements with bromine compounds' customers, which further demonstrates our ability to execute on our specialty-focused growth strategy. ICL's business mix continues to strengthen as we increase our focus on developing innovative products, novel materials and cost-effective processes that will create competitive advantages for ICL."

Zoller concluded: "Of all of the actions that ICL has taken, I am particularly proud of our initiatives focused on sustainable development goals and the recognitions we have received based on the rising quality of our work environment, our focused approach to sustainability and our leadership in industry innovation. These are all pillars that are critical to our ongoing growth and success."

For earnings history and earnings-related data on ICL (ICL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Z Squared outlines AI power strategy and Paradox Data acquisition
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c